I got the full complaint. This part I found int
Post# of 148231
(Total Views: 411)
Posted On: 08/28/2019 2:42:03 PM
Re: Coco Beans #6819
I got the full complaint.
This part I found interesting. Either NP or RP is lying here. One of them was saying we should get a patient injected soon for months. From everything, I have heard, I believe that information was coming from RP, not NP. I will specifically be interested to see on this point who was not telling the truth. Even Finesand was asking what is taking so long? it shouldn't be taking so long. So point #140 will be interesting.
139 The FDA approved CytoDyn’s IND submission for the TNBC trial on November 23, 2018, and CytoDyn announced the initiation of the TNBC trial to the public via press release on November 26, 2018. However, the anticipated timelines provided in the press release – that the Company intended to “start the TNBC trial this year” (i.e., by the end of 2018) and dose patients during the first quarter of 2019 – were not accurate or reasonable, given that the typical time (per industry standards) needed for preparing, planning, and obtaining all necessary approvals for the trial in advance of being able to start accepting patients is closer to 11 months, not 1 or 2 months.
140. Dr. Pestell and his team worked tirelessly to prepare the TNBC trial, such that it was ready to start accruing patients within 9 months. In the words of Dr. Massimo Cristofanilli, the principal investigator of the TNBC trial, being ready to accrue patients “just 9 months” after initiating the trial, was “a remarkable achievement in Oncology!”
This one was weird, ihub refernce:
177 These announcements led members of the public, posting on an “Investors Hub” message board (https://investorshub.advfn.com/Cytodyn-Inc-CYDY-4762/), to hypothesize about the reasons for Dr. Pestell’s termination. Several posters referred directly to the language in Dr. Pestell’s Employment Agreement, and speculated on which category of Cause was at issue.
This part I found interesting. Either NP or RP is lying here. One of them was saying we should get a patient injected soon for months. From everything, I have heard, I believe that information was coming from RP, not NP. I will specifically be interested to see on this point who was not telling the truth. Even Finesand was asking what is taking so long? it shouldn't be taking so long. So point #140 will be interesting.
139 The FDA approved CytoDyn’s IND submission for the TNBC trial on November 23, 2018, and CytoDyn announced the initiation of the TNBC trial to the public via press release on November 26, 2018. However, the anticipated timelines provided in the press release – that the Company intended to “start the TNBC trial this year” (i.e., by the end of 2018) and dose patients during the first quarter of 2019 – were not accurate or reasonable, given that the typical time (per industry standards) needed for preparing, planning, and obtaining all necessary approvals for the trial in advance of being able to start accepting patients is closer to 11 months, not 1 or 2 months.
140. Dr. Pestell and his team worked tirelessly to prepare the TNBC trial, such that it was ready to start accruing patients within 9 months. In the words of Dr. Massimo Cristofanilli, the principal investigator of the TNBC trial, being ready to accrue patients “just 9 months” after initiating the trial, was “a remarkable achievement in Oncology!”
This one was weird, ihub refernce:
177 These announcements led members of the public, posting on an “Investors Hub” message board (https://investorshub.advfn.com/Cytodyn-Inc-CYDY-4762/), to hypothesize about the reasons for Dr. Pestell’s termination. Several posters referred directly to the language in Dr. Pestell’s Employment Agreement, and speculated on which category of Cause was at issue.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼